You are here

Emma Walmsley

GSK CEO addresses declining trust in vaccines following Trump re-election

Clinical Trials Arena

Thu, 11/7/24 - 11:26 am

GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 mln pounds in 2023

Reuters

Fri, 03/1/24 - 11:16 am

executive compensation

GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year

Reuters

Thu, 11/30/23 - 11:12 pm

In busy year with Haleon spinoff and Zantac lawsuits, GSK CEO Emma Walmsley scored slight pay raise

Fierce Pharma

Mon, 03/13/23 - 10:06 am

GSK’s “crown jewels” already look tarnished

EP Vantage

Wed, 11/23/22 - 07:27 am

GSK shuffles execs and streamlines businesses as vaccines chief Connor heads for the exit

Fierce Pharma

Tue, 10/25/22 - 11:11 pm

GSK chief Emma Walmsley made $10.8M last year, lagging far behind fellow Big Pharma CEOs

Endpoints

Mon, 03/7/22 - 10:48 pm

Walmsley Targeted Again as Activists Renew Plea for New GSK CEO

BioSpace

Thu, 09/23/21 - 10:42 pm

AstraZeneca chief Soriot lends GlaxoSmithKline's Walmsley CEO wisdom, support as activist investors press for change

Fierce Pharma

Fri, 08/6/21 - 11:10 am

GSK backs CEO Walmsley, rejecting Elliott’s call to change board

Pharmaforum

Fri, 07/2/21 - 11:13 am

Elliott Management

Activist Investor Continues Campaign Against Walmsley, GSK Leadership

BioSpace

Thu, 07/1/21 - 10:34 am

GlaxoSmithKline, under activist pressure, gets some relief as Elliott won't push for sale or slash R&D: report

Fierce Pharma

Thu, 05/27/21 - 11:51 pm

Elliott Management

GlaxoSmithKline CEO Walmsley's pay falls to $9.7M as pandemic drags on profits

Fierce Pharma

Tue, 03/9/21 - 09:55 pm

GSK's Emma Walmsley granted damehood by Queen Elizabeth II

Endpoints

Tue, 10/13/20 - 10:03 pm

GlaxoSmithKline CEO Walmsley: COVID-19 is pharma's chance for redemption

Fierce Pharma

Wed, 09/30/20 - 10:44 pm

GSK’s Walmsley gets £2.5m pay rise after strong 2019

Pharmaforum

Thu, 03/5/20 - 11:26 am

women executives

GlaxoSmithKline's spinoff plan is here—and it may not be limited to consumer health

Fierce Pharma

Wed, 02/5/20 - 10:12 am

consumer health

GSK bets on tech to help boost lagging R&D as it looks to start 23andMe trial

Fierce Biotech

Wed, 01/22/20 - 11:10 am

GSK’s CEO Walmsley aiming for six new approvals in 2020

Pharmaforum

Tue, 01/14/20 - 10:07 am

belantamab mafodotin

GSK must continue to improve R&D, says CEO Walmsley

Pharmaforum

Tue, 11/12/19 - 10:07 am

Pages